143 related articles for article (PubMed ID: 16529036)
1. [Biomarkers, tumor markers and prognostic markers in breast cancer].
Kurebayashi J
Nihon Rinsho; 2006 Mar; 64(3):461-6. PubMed ID: 16529036
[TBL] [Abstract][Full Text] [Related]
2. [Biomarkers in breast cancer].
Kurebayashi J
Gan To Kagaku Ryoho; 2004 Jul; 31(7):1021-6. PubMed ID: 15272579
[TBL] [Abstract][Full Text] [Related]
3. [Tumor markers in breast cancer].
Kurebayashi J
Gan To Kagaku Ryoho; 2004 Nov; 31(12):2077-81. PubMed ID: 15570944
[TBL] [Abstract][Full Text] [Related]
4. Use of standard markers and incorporation of molecular markers into breast cancer therapy: Consensus recommendations from an International Expert Panel.
Kaufmann M; Pusztai L;
Cancer; 2011 Apr; 117(8):1575-82. PubMed ID: 21472705
[TBL] [Abstract][Full Text] [Related]
5. [Integration of new and future biomarkers in the treatment of breast cancer].
Würtz SØ; Henriksen KL; Lykkesfeldt A; Celis J; Brünner NA
Ugeskr Laeger; 2007 Sep; 169(36):2999-3003. PubMed ID: 17953881
[TBL] [Abstract][Full Text] [Related]
6. Mixture classification model based on clinical markers for breast cancer prognosis.
Zeng T; Liu J
Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
[TBL] [Abstract][Full Text] [Related]
7. Immunomarker studies of fine-needle cytopuncture cell blocks for tumor response prediction after preoperative chemotherapy and prognosis in operable nonmetastatic primary breast carcinoma.
Becette V; Lerebours F; Spyratos F; Menet E; Tubiana-Hulin M; Briffod M
Breast J; 2011; 17(2):121-8. PubMed ID: 21306468
[TBL] [Abstract][Full Text] [Related]
8. Biological markers in breast cancer prognosis and treatment.
Kesisis G; Kontovinis LF; Gennatas K; Kortsaris AH
J BUON; 2010; 15(3):447-54. PubMed ID: 20941809
[TBL] [Abstract][Full Text] [Related]
9. Emerging biomarkers in breast cancer care.
Napieralski R; Brünner N; Mengele K; Schmitt M
Biomark Med; 2010 Aug; 4(4):505-22. PubMed ID: 20701440
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer and neoadjuvant therapy: any predictive marker?
Vyzula R; Dusek L; Zaloudík J; Demlová R; Klimes D; Selvekerová S
Neoplasma; 2004; 51(6):471-80. PubMed ID: 15640958
[TBL] [Abstract][Full Text] [Related]
11. Biomarker research in breast cancer.
Maxwell C
Clin J Oncol Nurs; 2010 Dec; 14(6):771-83. PubMed ID: 21112854
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
[TBL] [Abstract][Full Text] [Related]
13. Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer.
Dowsett M; Dunbier AK
Clin Cancer Res; 2008 Dec; 14(24):8019-26. PubMed ID: 19088018
[TBL] [Abstract][Full Text] [Related]
14. Utility of cytologic specimens in the evaluation of prognostic and predictive factors of breast cancer: current issues and future directions.
Sneige N
Diagn Cytopathol; 2004 Mar; 30(3):158-65. PubMed ID: 14986295
[TBL] [Abstract][Full Text] [Related]
15. The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy.
Ross JS; Fletcher JA
Stem Cells; 1998; 16(6):413-28. PubMed ID: 9831867
[TBL] [Abstract][Full Text] [Related]
16. [Study on the clinical usefulness of NCC-ST-439 in breast cancer].
Takahashi H; Nakanishi K; Taguchi K; Hasumi T; Hamada H; Sasaki F; Hata Y; Uchino J
Gan To Kagaku Ryoho; 1991 Feb; 18(2):245-9. PubMed ID: 1992918
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of serum Her2/neu, BCL2, CA15-3 and CEA in breast cancer patients: a short follow-up.
Samy N; Ragab HM; El Maksoud NA; Shaalan M
Cancer Biomark; 2010; 6(2):63-72. PubMed ID: 20571232
[TBL] [Abstract][Full Text] [Related]
18. [Intratumoral biological markers in breast cancers].
Bougnoux P; Verrelle P; Chassagne J
Rev Prat; 1992 Oct; 42(15):1935-42. PubMed ID: 1485091
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic and predictive factors in breast cancer].
Bozhok AA; Semiglazov VF; Semiglazov VV; Arzumanov AS; Klettsel' AE
Vopr Onkol; 2005; 51(4):434-43. PubMed ID: 16308974
[TBL] [Abstract][Full Text] [Related]
20. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
